Bayer/Cognitive Assessments With Multiple Sclerosis Subjects

Completed

Conditions studied: Multiple Sclerosis, Relapsing-remitting, Multiple Sclerosis, Secondary Progressive

In brief

This study is designed to identify a brief screening evaluation for MS patients that is sensitive and specific to the MS population and which correlates with the findings of our standard-of-care neuropsychological assessments.

Key facts

Study ID

NCT00888277

Run by

University of Louisville

People needed

74

Starts

2009-05-01

Expected to finish

2010-01-01

Last updated by the study team

2013-11-04

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• EDSS at last visit ≤ 7.0
• Relapsing/Remitting or Secondary Progressive MS

You may not qualify if…

• Severe Depressive Illness: Beck Depression Inventory Score > 55.
• Unable to read with/without glasses- Visual Acuity better than or equal to 20/60 in one eye.
• Unwilling to sign Informed Consent.
• Evidence on clinical examination of severe dementia at discretion of evaluating neurologist.

Where it is running

• University of Louisville — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.